Armata Pharmaceuticals received an additional $3.7 million in non-dilutive funding from the U.S. Department of War to support the Phase 3 clinical development of AP-SA02, a bacteriophage therapy targeting complicated Staphylococcus aureus bacteremia, including antibiotic-resistant strains. This funding increases total DoW support for the program to $32.4 million, highlighting government commitment to new treatments for serious bacterial infections. AP-SA02 aims to complement existing antibiotics and improve patient outcomes, with the Phase 3 trial expected to start in the second half of 2026.
Armata Pharmaceuticals' recent $3.7 million funding boost from the U.S. Department of War provides context for readers. For those tracking the health sector, 47 out of 100 US health stocks on Pluang rose while 42 fell as of Sep 23, 2026 17:01 WIB. Notable prices include AstraZeneca at USD 166.30 with a 1-day change of -1.23%, Becton Dickinson at USD 180.78 down 1.21%, and 10X Genomics at USD 81.64 up 1.16%.
Avanti Gold Corp. completed a private placement raising C$51.75 million by issuing 103.5 million units at C$0.50 each, including an over-allotment option. The funds will finance a 42,000-metre drilling program at the Misisi Project in the Democratic ...
US spot Bitcoin ETFs attracted $714.75 million in net inflows on September 22, marking the fourth consecutive day of gains and bringing total net assets to $110.84 billion. Over the four-day period from September 17 to 22, inflows totaled approximate...
Intel's stock surged 37.5% in the past month, surpassing Wall Street's average price target due to strong revenue growth driven by AI and data center demand. The company's Q2 fiscal 2026 results showed a 25.4% revenue increase and a 59% jump in data ...
Base's decentralized exchange Aerodrome offers triple-digit APRs to liquidity providers in tokenized US stock pools paired with USDC. These tokenized stocks, backed 1:1 by real shares and represented as B20 tokens, allow global investors to trade and...
Alpaca, a FINRA-regulated broker-dealer, now clears or custodizes about 94% of tokenized US equities, managing over $1.5 billion in underlying stocks through its Instant Tokenization Network (ITN). ITN allows institutions to mint tokens directly from...
